Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Nicox S.A. (Euronext:COX) jumped €2.26 (21%) to €12.85 Wednesday after FDA approved
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury